Neumora Therapeutics Management
Management criteria checks 1/4
Neumora Therapeutics' CEO is Henry Gosebruch, appointed in Jul 2023, has a tenure of 1.33 years. total yearly compensation is $22.00M, comprised of 1.5% salary and 98.5% bonuses, including company stock and options. directly owns 0.32% of the company’s shares, worth $5.07M. The average tenure of the management team and the board of directors is 1.6 years and 3.9 years respectively.
Key information
Henry Gosebruch
Chief executive officer
US$22.0m
Total compensation
CEO salary percentage | 1.5% |
CEO tenure | 1.3yrs |
CEO ownership | 0.3% |
Management average tenure | 1.6yrs |
Board average tenure | 3.9yrs |
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$294m |
Jun 30 2024 | n/a | n/a | -US$274m |
Mar 31 2024 | n/a | n/a | -US$254m |
Dec 31 2023 | US$22m | US$338k | -US$236m |
Compensation vs Market: Henry's total compensation ($USD22.00M) is above average for companies of similar size in the US market ($USD5.54M).
Compensation vs Earnings: Insufficient data to compare Henry's compensation with company performance.
CEO
Henry Gosebruch (51 yo)
1.3yrs
Tenure
US$21,999,269
Compensation
Mr. Henry O. Gosebruch serves as President, Chief Executive Officer and Director at Neumora Therapeutics, Inc. since July 2023. He serves as an Independent Director at Acelyrin, Inc. since March 17, 2023....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman | 4.8yrs | US$8.57m | 4.73% $ 73.9m | |
President | 1.3yrs | US$22.00m | 0.32% $ 5.1m | |
Chief Legal Officer | less than a year | US$4.41m | no data | |
Head of Research & Development | 1.2yrs | US$13.58m | 0% $ 0 | |
Co-Founder & COO | 1.8yrs | no data | 0.18% $ 2.8m | |
Co-Founder & Advisor | no data | no data | no data | |
Chief Financial Officer | 3.4yrs | US$3.82m | 0.086% $ 1.3m | |
Principal Accounting Officer | no data | no data | 0.0024% $ 37.0k | |
Chief Technical Operations Officer | 1.3yrs | no data | no data | |
Chief Scientific Officer | 2.8yrs | no data | no data | |
Chief Human Resources Officer | 2.2yrs | no data | no data | |
Chief Data Sciences Advisor | no data | no data | no data |
1.6yrs
Average Tenure
51yo
Average Age
Experienced Management: NMRA's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman | 4.8yrs | US$8.57m | 4.73% $ 73.9m | |
President | 1.3yrs | US$22.00m | 0.32% $ 5.1m | |
Independent Director | 3.9yrs | US$485.53k | 0.012% $ 194.3k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 4.8yrs | US$686.60k | 0.017% $ 267.0k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Technology Advisory Board | no data | no data | no data | |
Independent Director | 2.2yrs | US$671.20k | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Technology Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
3.9yrs
Average Tenure
51yo
Average Age
Experienced Board: NMRA's board of directors are considered experienced (3.9 years average tenure).